Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab.
暂无分享，去创建一个
G. Macedo | K. Geboes | J. Cotter | A. Albuquerque | P. Lago | F. Carneiro | F. Magro | P. Peixe | F. Portela | J. Lopes | M. Moreira | S. Rodrigues | S. Lopes | J. Afonso | S. Lopes | Mário Rui Silva | Pedro Monteiro | Castro Lopes | Lucília Monteiro | Luís Veloso | Claudi Camila | M. Silva